Basic Information
| ID | DRAMP21012 |
| Sequence | KILRGVCKKIMRTFLRRISKDILTGKK |
| Length | 27 |
| Name | NK-2 (Mammals, Animals) |
| Source | Mammal |
| Activity | Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antitumor |
| Pathogen | [Ref.29043494]Gram-positive bacteria : Staphylococcus aureus (MIC=2 μM), Staphylococcus epidermidis (MIC=2 μM);##Gram-negative bacteria : Escherichia coli (MIC=4 μM), Pseudomonas aeruginosa (MIC=8 μM) |
| Hemolytic Activity | [Ref.29043494] 2.5% hemolysis at 10 μg/ml , 8% hemolysis at 25 μg/ml , 22% hemolysis at 50 μg/ml , 32.5% hemolysis at 75 μg/ml , 36% hemolysis at 150 μg/ml , 38% hemolysis at 300 μg/ml against human red blood cells |
| Cytotoxicity | [Ref.29043494] IC50 = 25.1 μM against NK-2. ##IC50 = 8.4 μM against EJ. ##IC50 = 4.1 μM against PC-3. ##IC50 = 10.1 μM against T24. ##IC50 = 13.7 μM against HL-60. ##The proliferation inhibition activity on K562 is not significant. |
| N-terminal Modification | Free |
| C-terminal Modification | Amidation |
| Linear/Cyclic/Branched | Linear |
| Uniprot |
|
| PDB |
|
| 3D View | |
|---|
| PDB Download | Download PDB Predicted by Alphafold2 |
|---|
| PubMed ID | 29043494 |
|---|